Insider reports 400-share purchase and 17,000 RSUs

XERS reported insider transactions including an open-market purchase of 400 common shares and an issuance of 17,000 restricted stock units (RSUs).

Rhea-AI Filing Summary

XERS reported insider transactions including an open-market purchase of 400 common shares and an issuance of 17,000 restricted stock units (RSUs). The filing lists transaction dates of 05/17/2017 for the purchase and 12/28/2017 for the RSU award; the cover shows 07/06/2026 as a filing header date. The actions are recorded as an open-market purchase and an issuer grant.

Insights

Equity Compensation Lawyer

Form 144 discloses a small purchase and a prior RSU award; these are routine disclosure items.

The filing lists an open-market purchase of 400 shares completed on 05/17/2017 and an issuer-reported grant of 17,000 RSUs dated 12/28/2017. These entries are presented as transaction records rather than corrective allegations.

Timing and cash-flow treatment are shown in-line: the purchase is marked Cash; the RSU line is identified as Restricted Stock Units. Subsequent filings would clarify vesting or tax-withholding details if material.

Key Figures

Open-market purchase: 400 shares Restricted Stock Units: 17,000 RSUs Filing header date: 07/06/2026

3 metrics

Open-market purchase 400 shares transaction dated 05/17/2017

Restricted Stock Units 17,000 RSUs issuer grant dated 12/28/2017

Filing header date 07/06/2026 date shown in excerpt header

Key Terms

Form 144, Open Market Purchase, Restricted Stock Units

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Open Market Purchase market

"Open Market Purchase | Issuer | 400 | 05/17/2017"

An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 17,000 | 12/28/2017"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

What insider transactions does XERS report in this Form 144?

The filing reports a 400-share open-market purchase and a 17,000 RSU grant. Dates shown are 05/17/2017 for the purchase and 12/28/2017 for the RSU award.

Does the Form 144 show how the 400 shares were paid for?

Yes. The 400-share transaction is listed as an Open Market Purchase with the consideration marked as Cash. No dollar amount per share is provided in the excerpt.

Are the 17,000 restricted stock units (RSUs) reported as sold or issued?

They are reported as an issuer line dated 12/28/2017 under Restricted Stock Units, indicating an award/issuance, not a sale or resale.

What filing date appears on this excerpt for the Form 144?

The header of the excerpt displays 07/06/2026. Transaction line dates remain in 2017: 05/17/2017 and 12/28/2017.

Who is the broker or executing party shown for these transactions?

The excerpt names Morgan Stanley Smith Barney LLC with an address at 1 New York Plaza as the broker/executing firm for the reported transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 04:39 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001875714
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	XERIS BIOPHARMA HOLDINGS, INC.
SEC File Number	001-40880
Address of Issuer	1375 West Fulton Street, Suite 1300 Chicago ILLINOIS 60607
Phone	8444455704
Name of Person for Whose Account the Securities are To Be Sold	STEVEN PIEPER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	17400	144072.00	172642055	07/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/17/2017	Open Market Purchase	Issuer			400	05/17/2017	Cash
Common	12/28/2017	Restricted Stock Units	Issuer			17000	12/28/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 12/28/2017 through 01/03/2025. The securities to be sold were acquired upon open market purchases during the period of 05/17/2017 through 02/13/2019.
Date of Notice	07/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Steven Pieper
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)